If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSE Regulatory News (SSE)

Share Price Information for SSE (SSE)

Share Price is delayed by 15 minutes
Get Live Data
2,507.00    47.00 (1.91%)
Bid:
2,499.00
Ask:
2,500.00
Spread: 1.00 (0.04%)
Market Cap: £30.24b
SSE Live PriceLast checked at - London Stock Exchange

Intraday SSE Share Chart

Board Changes

25 May 2022 07:00

RNS Number : 6836M
SSE PLC
25 May 2022
 

SSE plc

BOARD CHANGES

 

Appointment of New Non-Executive Director - John Bason

The Board of SSE plc is pleased to announce the appointment of John Bason as a non-Executive Director, effective 1 June 2022, following a comprehensive search and selection process. 

John brings a wealth of experience from a distinguished executive and non-executive career in global businesses, which will be invaluable to SSE as it continues to expand to new international markets.

He will join SSE's Audit Committee on appointment and, in due course, it is intended that he will succeed Peter Lynas as Audit Committee Chair, allowing for a smooth handover as Peter Lynas enters the ninth year of his time on SSE's Board in summer 2022. He will also join the Nomination Committee.

John served for more than a decade as a non-Executive Director on the Board of FTSE-100 company, Compass Group PLC, which operates in around 45 countries and where he chaired the Audit Committee for ten years. He is currently Chair of FareShare, the UK's network of charitable food redistributors and a non-Executive Director of Bloomsbury Publishing plc.

In his executive career, John has been Finance Director of Associated British Foods plc, the diversified international food, ingredients and retail group since 1999. The company employs 128,000 people and has operations in 53 countries across Europe, Asia, the Americas, Australia and Africa.

Each Director of SSE plc is subject to annual re-appointment and this new appointment to the Board from 1 June 2022, will be the subject of a resolution at SSE's Annual General Meeting 2022. Following this appointment, the Board of SSE plc will comprise the Chair, three Executive Directors and nine non-Executive Directors; and will comprise seven men and six women.

Looking ahead, the Board and Nomination Committee will continue to assess the Board's composition with a view to ensuring it has the experience and skillset required to deliver on SSE's significant growth potential in the transition to net zero, taking account of shareholder views.

Sir John Manzoni, Chair of SSE plc, said:

"After a comprehensive search, we are delighted to add someone of John's calibre and track record to the Board. His significant experience as a finance director in major global companies means he has both the commercial acumen and international perspective to provide constructive challenge and guidance as SSE delivers its Net Zero Acceleration Programme, building on its position as the UK's clean energy champion whilst bringing its low-carbon infrastructure capabilities to new geographies."

SSE confirms this announcement is made in accordance with LR9.6.11R(1) with no additional information required to be disclosed under the LR9.6.13R.

Planned changes to the Board

As part of the ongoing succession plan, Dame Sue Bruce, non-Executive Director, will step down from the Board on 31 March 2023. Dame Sue joined the Board in September 2013 and has played a key role in all aspects of the Board's activity and deliberations, including in the roles of Remuneration Committee Chair and non-Executive Director for Employee Engagement. Mel Smith, who joined the Board as a non-Executive Director in January 2019 and serves on the Remuneration Committee will take on the position as Remuneration Committee Chair from 1 April 2023. Elish Angiolini, who joined the Board as a non-Executive Director in September 2021 will take on the position as non-Executive Director for Employee Engagement from the same date.

 

 

 

 

Enquiries

Investors

SSE Investor Relations

ir@sse.com

Sally Fairbairn, Michael Livingston

+44 (0)345 0760 530

Media

SSE Media

media@sse.com

Sam Peacock,

Glenn Barber

+44 (0)345 0760 530

MHP Communications

Oliver Hughes

+44 (0)7885 224 532

Simon Hockridge

+44 (0)7709 496 125

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAIMMTMTMTTTT
Date   Source Headline
10th Aug 20233:15 pmRNSDirector/PDMR Shareholding
3rd Aug 20233:27 pmRNSScrip Reference Price
1st Aug 20233:47 pmRNSHolding(s) in Company
1st Aug 20233:45 pmRNSHolding(s) in Company
1st Aug 20233:29 pmRNSTotal Voting Rights
28th Jul 20234:11 pmRNSHolding(s) in Company
28th Jul 20239:34 amRNSHolding(s) in Company
24th Jul 20233:59 pmRNSHolding(s) in Company
24th Jul 202311:26 amRNSDirector/PDMR Shareholding
20th Jul 20234:57 pmRNSResult of AGM
20th Jul 20237:00 amRNSQ1 Trading Statement
14th Jul 20232:06 pmRNSDirector/PDMR Shareholding
10th Jul 20234:07 pmRNSDirector/PDMR Shareholding
3rd Jul 20237:00 amRNSTotal Voting Rights
26th Jun 20234:55 pmRNSDirector/PDMR Shareholding
16th Jun 20231:19 pmRNSPublication of Annual Report and Accounts 2023
9th Jun 20239:08 amRNSDirector/PDMR Shareholding
7th Jun 20235:44 pmRNSDirector/PDMR Shareholding
1st Jun 202312:49 pmRNSTotal Voting Rights
25th May 20233:22 pmRNSFinal Dividend Timetable
25th May 20233:18 pmRNSDirector/PDMR Shareholding
24th May 20237:00 amRNSPreliminary Results for the year to 31 March 2023
10th May 20239:26 amRNSDirector/PDMR Shareholding
3rd May 202310:38 amRNSTotal Voting Rights
21st Apr 202312:30 pmRNSDirectorate Change
11th Apr 20232:16 pmRNSDirector/PDMR Shareholding
3rd Apr 20237:00 amRNSTotal Voting Rights
30th Mar 20237:00 amRNSDirectorate Change
30th Mar 20237:00 amRNSNotification of Closed Period
29th Mar 202310:10 amRNSDirector/PDMR Shareholding - Replacement
29th Mar 202310:07 amRNSDirector/PDMR Shareholding
15th Mar 20231:17 pmRNSDirector/PDMR Shareholding
13th Mar 20232:35 pmRNSDirector/PDMR Shareholding
7th Mar 20233:15 pmRNSDirector/PDMR Shareholding
1st Mar 20234:23 pmRNSAdditional Listing
1st Mar 20237:00 amRNSTotal Voting Rights
28th Feb 20239:38 amRNSBlock Listing Six-Monthly Return
14th Feb 20231:07 pmRNSInterim Dividend Scrip Alternative
13th Feb 20234:36 pmRNSINTERIM DIVIDEND SCRIP ALTERNATIVE
9th Feb 202312:26 pmRNSDirector/PDMR Shareholding
1st Feb 202311:57 amRNSTotal Voting Rights
31st Jan 20233:12 pmRNSDirector/PDMR Shareholding
20th Jan 20237:00 amRNSQ3 Trading Statement
19th Jan 202312:52 pmRNSScrip Reference Price
19th Jan 20239:07 amRNSTR-1 Notification of Major Shareholding
18th Jan 202312:45 pmRNSTR-1 Notification of Major Shareholding
18th Jan 202312:41 pmRNSTR-1 Notification of Major Shareholding
18th Jan 202312:14 pmRNSTR-1 Notification of Major Shareholding
10th Jan 20239:33 amRNSDirector/PDMR Shareholding
9th Jan 202310:48 amRNSTR-1 Notification of Major Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.